europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio welcomes renewed commitment to the EU Bioeconomy

11/10/2018
PRESS RELEASE
IB1

EuropaBio welcomes renewed commitment to the EU Bioeconomy

EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy.

Brussels 11 October 2018 Today, EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy. The updated plan signals the EU’s continued commitment towards establishing itself as a world leader in renewable resource efficiency, catalysed by transformative industrial biotechnology.

Europe’s leadership in this field has already significantly boosted activity, investment, technological breakthrough and interest in developing dynamic bioeconomies throughout the Member States and regions.

An innovation-driven bioeconomy, with increased sustainability as its end goal, is now also providing renewability, circularity and multifunctionality whilst helping to deliver solutions to the UN SDGs. Industrial biotechnology plays a central role as an enabling technology, using smart science to develop a wide variety of renewable, bio-based chemicals, materials, pharmaceuticals, food, feed and fuels.

Since the publication of the first EU strategy in 2012, the increase in EU R&I funds has also resulted in real progress towards the development of a bio-based economy, with the €3.7 billion Bio-based Industries Joint Undertaking (BBI JU) attracting investments, spurring innovation and creating new value chains.

Commenting on the strategy launch, Agnes Borg, Director for Industrial Biotechnology at EuropaBio said: “We now call on the EU to shore up the updated strategy with a comprehensive high-level commitment towards building upon the success of the BBI JU. This will create jobs and growth and will help establish the EU as hub for renewable, resource efficient clean-tech on the road to 2030”.

EuropaBio welcomes renewed commitment to the EU Bioeconomy


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

01/02/2023

Joint Statement: The Data Act is a leap into the unknown


Read more
31/01/2023

EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach


Read more
17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more

Important links

  • Delivering Europe’s ambitions in rare disease
  • Joint Statement: The Data Act is a leap into the unknown

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies